文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

癌症统计数据,2013 年。

Cancer statistics, 2013.

机构信息

Surveillance Information, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA 30303-1002, USA.

出版信息

CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.


DOI:10.3322/caac.21166
PMID:23335087
Abstract

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. A total of 1,660,290 new cancer cases and 580,350 cancer deaths are projected to occur in the United States in 2013. During the most recent 5 years for which there are data (2005-2009), delay-adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.5% per year in women. Overall, cancer death rates have declined 20% from their peak in 1991 (215.1 per 100,000 population) to 2009 (173.1 per 100,000 population). Death rates continue to decline for all 4 major cancer sites (lung, colorectum, breast, and prostate). Over the past 10 years of data (2000-2009), the largest annual declines in death rates were for chronic myeloid leukemia (8.4%), cancers of the stomach (3.1%) and colorectum (3.0%), and non-Hodgkin lymphoma (3.0%). The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of approximately 1.18 million deaths from cancer, with 152,900 of these deaths averted in 2009 alone. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket and other underserved populations.

摘要

每年,美国癌症协会都会预估当年美国新癌症病例和死亡人数,并根据美国国家癌症研究所、疾病控制与预防中心、北美癌症中心协会的发病率数据以及美国国家卫生统计中心的死亡率数据,编制最新的癌症发病率、死亡率和生存率数据。预计 2013 年美国将有 166.029 例新癌症病例和 58.035 例癌症死亡。在最近有数据(2005-2009 年)的 5 年期间,男性的癌症发病率每年略有下降(0.6%),女性保持稳定,而男性的癌症死亡率每年下降 1.8%,女性每年下降 1.5%。总的来说,自 1991 年(每 10 万人 215.1 人)达到峰值以来,癌症死亡率下降了 20%,到 2009 年降至每 10 万人 173.1 人。所有 4 个主要癌症部位(肺癌、结直肠癌、乳腺癌和前列腺癌)的死亡率仍在继续下降。在过去 10 年的数据(2000-2009 年)中,死亡率下降幅度最大的癌症是慢性髓性白血病(8.4%)、胃癌(3.1%)和结直肠癌(3.0%)以及非霍奇金淋巴瘤(3.0%)。自 1990 年以来,男性和 1991 年以来女性的总体癌症死亡率下降,意味着避免了约 118 万人死于癌症,仅 2009 年就避免了 15.29 万人死亡。通过将现有的癌症控制知识应用于所有人群,特别是社会经济地位最低的群体和其他服务不足的人群,可以加速这一进展。

相似文献

[1]
Cancer statistics, 2013.

CA Cancer J Clin. 2013-1-17

[2]
Cancer statistics, 2012.

CA Cancer J Clin. 2012-1-4

[3]
Cancer statistics, 2015.

CA Cancer J Clin. 2015-1-5

[4]
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

CA Cancer J Clin. 2011-6-17

[5]
Cancer statistics, 2010.

CA Cancer J Clin. 2010-7-7

[6]
Cancer statistics, 2020.

CA Cancer J Clin. 2020-1-8

[7]
Cancer statistics, 2014.

CA Cancer J Clin. 2014-1-7

[8]
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.

Cancer. 2018-5-22

[9]
Cancer statistics, 2009.

CA Cancer J Clin. 2009

[10]
Annual report to the nation on the status of cancer, part I: National cancer statistics.

Cancer. 2020-5-15

引用本文的文献

[1]
Simulation Modeling of Oral Cancer Development with Risk Stratification: How Potential Screening Programs Can Be Evaluated.

MDM Policy Pract. 2025-8-19

[2]
Cytokine Regulation and Oxidative Stress in Helicobacter Pylori-Associated Gastric Adenocarcinoma at Different Stages: Insights from a Cross-Sectional Study.

Int J Mol Sci. 2025-8-6

[3]
Blinatumomab in pediatric B-acute lymphoblastic leukemia.

Front Immunol. 2025-7-23

[4]
Prognostic value of circulating uric acid in gastrointestinal cancers, a systematic review and meta-analysis.

Gastroenterol Hepatol Bed Bench. 2025

[5]
A Review Discussing Synthesis and Translational Studies of Medicinal Agents Targeting Sphingolipid Pathways.

Biomolecules. 2025-7-16

[6]
CDK12 inhibition enhances oxaliplatin efficacy in gastric cancer by suppressing the MAPK signaling pathway.

J Gastrointest Oncol. 2025-6-30

[7]
A molecular circuit regulates fate plasticity in emerging and adult AT2 cells.

bioRxiv. 2025-5-7

[8]
Study on the risk factors for colorectal polyp recurrence: a cross-sectional retrospective cohort study.

Front Med (Lausanne). 2025-6-18

[9]
Elevated KRAS protein level is associated with better survival in pancreatic cancer.

BMC Cancer. 2025-7-1

[10]
Surgery of Early-Stage Pancreatic Cancer.

Visc Med. 2025-5-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索